Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
|Articles|July 2, 2020
- Pharmaceutical Technology-07-02-2020
- Volume 44
- Issue 7
Pump Tubing System
AdvantaPure’s GORE STA-PURE Pump Tubing systems can now overmold into any manifold tubing assembly as its pump element.
AdvantaPure’s GORE STA-PURE Pump Tubing systems can now overmold into any manifold tubing assembly as its pump element. Designed for optimal performance in peristaltic pumps, the system is made with platinum-cured silicone rubber and ePTFE for a fluid transfer product that uses overmolding technology to provide a smooth contact surface for fluid flow.
The tubing system can also lessen the risk of tubing ruptures in pumps, withstand operating pressures up to 100 psig, maintain consistent flow rates, lower spallation, and support sterile fluid processing.
Articles in this issue
over 6 years ago
Performing Remote Audits During the Pandemicover 6 years ago
Demand for Custom Dosage Forms Fuels Innovationover 6 years ago
Learning Regulatory Lessons in Times of a Crisisover 6 years ago
Business on Hold? EMA’s Full Recovery in Questionover 6 years ago
Taking a Controlled Approachover 6 years ago
Unprecedented Times in Vaccinesover 6 years ago
No Business, Like Brexit Businessover 6 years ago
Innovating Continuous Twin-Screw Granulation with Foam DeliveryRelated to this article
The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral development and manufacturing.
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Richard Jaenisch examines whether FDA's NAM pathway truly shortens drug pipelines or just shifts the evidentiary burden elsewhere.
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Trending on Pharmaceutical Technology
1
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
2
What the Olanzapine Depot Approval Means for CMC Teams
3
PharmTech AI Pulse Check: Availability Bias Threatens AI Regulatory Reviews
4
Complying with International Pharmacopoeias
5